Abstract
Dysbiosis in the gut microbiome, particularly concerning the synchronous crosstalk between the gut and the liver, has been associated with various diseases. This study profiles the gut microbiome in liver diseases among Egyptian patients, with a focus on the hepatitis C virus (HCV) and hepatocellular carcinoma (HCC), both of which are highly prevalent in Egypt. Utilizing shotgun metagenomic sequencing, we analyzed microbial gene catalogs and taxonomic profiles from 46 Egyptian patients categorized into five groups: healthy individuals, liver disease patients of different etiologies, post-HCV, treated HCV, and HCV-HCC patients. Healthy and treated HCV patients exhibited distinct microbial profiles characterized by an abundance of beneficial bacteria, Faecalibacterium and Bifidobacterium (p < 0.05), associated with anti-inflammatory shortchain fatty acid production. Conversely, liver disease and HCC patients displayed increased pathogenic bacteria, Escherichia (p < 0.05), and genes linked to inflammation and oncogenesis, including lipopolysaccharide biosynthesis. These findings suggest a dominance of Faecalibacterium in healthy Egyptians, likely attributable to fiber-rich diets, and cytochrome P450 genes as potential HCC biomarkers, possibly connected to aflatoxin exposure. Treated HCV patients showed significant microbiome recovery, reflecting effective antiviral therapy. These findings emphasize that Egypt-specific factors, such as persistent resistance genes post-HCV due to antibiotic use and the prominence of bile acid metabolism genes, are influenced by high HCV prevalence and environmental exposures like aflatoxins. Taken together, the results highlight the need for region-specific microbiome research priorities in Egypt and underscore how local dietary, clinical, and environmental factors may shape future objectives in understanding liver disease pathogenesis and prevention.
School
School of Sciences and Engineering
Department
Biotechnology Program
Degree Name
PhD in Applied Science
Graduation Date
Fall 2-15-2026
Submission Date
1-24-2026
First Advisor
Hassan Azzazy
Second Advisor
Ahmed Moustafa
Committee Member 1
Khaled Abou-Aisha
Committee Member 2
Khaled Ammer
Committee Member 3
Mohamed Salama
Extent
105p.
Document Type
Doctoral Dissertation
Institutional Review Board (IRB) Approval
Approval has been obtained for this item
Disclosure of AI Use
Thesis editing and/or reviewing
Recommended Citation
APA Citation
Zahra, M. A.
(2026).Metagenomic Profiling of Gut Microbiome Signatures Across Liver Disease Stages and HCV-Related Hepatocellular Carcinoma in Egyptian Patients [Doctoral Dissertation, the American University in Cairo]. AUC Knowledge Fountain.
https://fount.aucegypt.edu/etds/2666
MLA Citation
Zahra, Marwa A.. Metagenomic Profiling of Gut Microbiome Signatures Across Liver Disease Stages and HCV-Related Hepatocellular Carcinoma in Egyptian Patients. 2026. American University in Cairo, Doctoral Dissertation. AUC Knowledge Fountain.
https://fount.aucegypt.edu/etds/2666
Included in
Biotechnology Commons, Genomics Commons, Molecular Genetics Commons, Pathogenic Microbiology Commons
